NO20014875L - Promedikamenter for trombin inhibitorer - Google Patents
Promedikamenter for trombin inhibitorerInfo
- Publication number
- NO20014875L NO20014875L NO20014875A NO20014875A NO20014875L NO 20014875 L NO20014875 L NO 20014875L NO 20014875 A NO20014875 A NO 20014875A NO 20014875 A NO20014875 A NO 20014875A NO 20014875 L NO20014875 L NO 20014875L
- Authority
- NO
- Norway
- Prior art keywords
- promedients
- thrombin inhibitors
- thrombin
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B43/00—Formation or introduction of functional groups containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19915930 | 1999-04-09 | ||
DE19934123 | 1999-07-23 | ||
DE19947920 | 1999-10-06 | ||
PCT/EP2000/003009 WO2000061609A2 (fr) | 1999-04-09 | 2000-04-05 | Promedicaments d'inhibiteurs de la thrombine |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20014875D0 NO20014875D0 (no) | 2001-10-08 |
NO20014875L true NO20014875L (no) | 2001-11-13 |
Family
ID=27219075
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20014875A NO20014875L (no) | 1999-04-09 | 2001-10-08 | Promedikamenter for trombin inhibitorer |
Country Status (18)
Country | Link |
---|---|
US (1) | US7144902B1 (fr) |
EP (1) | EP1165601A2 (fr) |
JP (1) | JP2002542165A (fr) |
KR (1) | KR20010108481A (fr) |
CN (1) | CN1355810A (fr) |
AU (1) | AU765244B2 (fr) |
BG (1) | BG105986A (fr) |
BR (1) | BR0009674A (fr) |
CA (1) | CA2370267A1 (fr) |
HK (1) | HK1046289A1 (fr) |
HU (1) | HUP0202401A3 (fr) |
IL (1) | IL145772A0 (fr) |
NO (1) | NO20014875L (fr) |
NZ (1) | NZ515026A (fr) |
PL (1) | PL352824A1 (fr) |
SK (1) | SK14222001A3 (fr) |
TR (1) | TR200102912T2 (fr) |
WO (1) | WO2000061609A2 (fr) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10064797A1 (de) * | 2000-12-22 | 2002-06-27 | Knoll Ag | Orale und parenterale pharmazeutische Formulierung, umfassend eine niedermolekulare Thrombininhibitor-Pro-Pharmakon |
WO2004002985A1 (fr) * | 2002-06-27 | 2004-01-08 | Lg Life Sciences Ltd. | Compose peptidique inhibiteur de la thrombine |
CA2525940A1 (fr) | 2003-05-16 | 2004-11-25 | National Institute For Biological Standards And Control (Nibsc) | Melange |
USRE46830E1 (en) | 2004-10-19 | 2018-05-08 | Polypeptide Laboratories Holding (Ppl) Ab | Method for solid phase peptide synthesis |
EP1964578A3 (fr) * | 2005-05-05 | 2008-11-05 | Chroma Therapeutics Limited | Conjugués d'un ester d'aminoacide alpha et d'un médicament hydrolysables par la carboxylestérase. |
SI1879573T1 (sl) | 2005-05-10 | 2013-04-30 | Incyte Corporation Experimental Station | Modulatorji indolamin 2,3-dioksigenaze in postopki za uporabo le-te |
ES2540561T3 (es) | 2005-12-20 | 2015-07-10 | Incyte Corporation | N-hidroxiamidinoheterociclos como moduladores de indolamina 2,3-dioxigenasa |
CL2007002650A1 (es) | 2006-09-19 | 2008-02-08 | Incyte Corp | Compuestos derivados de heterociclo n-hidroxiamino; composicion farmaceutica, util para tratar cancer, infecciones virales y desordenes neurodegenerativos entre otras. |
JP5319532B2 (ja) | 2006-09-19 | 2013-10-16 | インサイト・コーポレイション | インドールアミン2,3−ジオキシゲナーゼのモジュレーターとしてのn−ヒドロキシアミジノヘテロサイクル |
NO2824100T3 (fr) | 2008-07-08 | 2018-07-21 | ||
WO2011075684A1 (fr) | 2009-12-18 | 2011-06-23 | Activesite Pharmaceuticals, Inc. | Promédicaments d'inhibiteurs de la kallicréine plasmatique |
US9206123B2 (en) | 2009-12-18 | 2015-12-08 | Activesite Pharmaceuticals, Inc. | Prodrugs of inhibitors of plasma kallikrein |
EP2697196A1 (fr) | 2011-04-13 | 2014-02-19 | Activesite Pharmaceuticals, Inc. | Promédicaments d'inhibiteurs de la kallicréine plasmatique |
ME03792B (fr) | 2013-11-08 | 2021-04-20 | Incyte Holdings Corp | Procédé pour la synthèse d'un inhibiteur de l'indoleamine 2,3-dioxygénase |
JP6556146B2 (ja) * | 2014-08-26 | 2019-08-07 | 武田薬品工業株式会社 | 複素環化合物 |
CN106674190B (zh) * | 2016-12-13 | 2019-05-10 | 台州市创源工业技术有限公司 | 一种2-噻吩甲胺的合成方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA951617B (en) * | 1994-03-04 | 1997-02-27 | Lilly Co Eli | Antithrombotic agents. |
AR005245A1 (es) * | 1995-12-21 | 1999-04-28 | Astrazeneca Ab | Prodrogas de inhibidores de trombina, una formulación farmaceutica que las comprende, el uso de dichas prodrogas para la manufactura de un medicamento y un procedimiento para su preparacion |
TW523513B (en) | 1996-03-01 | 2003-03-11 | Akzo Nobel Nv | Serine protease inhibitors |
DE19632773A1 (de) * | 1996-08-14 | 1998-02-19 | Basf Ag | Neue Thrombininhibitoren |
EP1049673A1 (fr) * | 1998-01-26 | 2000-11-08 | Basf Aktiengesellschaft | Amidines heterocycliques utilisees comme inhibiteurs de la kallicreine |
EP1051431A1 (fr) * | 1998-01-26 | 2000-11-15 | Basf Aktiengesellschaft | Inhibiteurs de la thrombine |
KR20000047461A (ko) * | 1998-12-29 | 2000-07-25 | 성재갑 | 트롬빈 억제제 |
JP4489976B2 (ja) * | 1999-04-09 | 2010-06-23 | ビーエーエスエフ ソシエタス・ヨーロピア | 補体プロテアーゼの低分子インヒビター |
-
2000
- 2000-04-05 EP EP00920661A patent/EP1165601A2/fr not_active Withdrawn
- 2000-04-05 JP JP2000611551A patent/JP2002542165A/ja active Pending
- 2000-04-05 CN CN00807958A patent/CN1355810A/zh active Pending
- 2000-04-05 KR KR1020017012870A patent/KR20010108481A/ko not_active Application Discontinuation
- 2000-04-05 WO PCT/EP2000/003009 patent/WO2000061609A2/fr not_active Application Discontinuation
- 2000-04-05 CA CA002370267A patent/CA2370267A1/fr not_active Abandoned
- 2000-04-05 IL IL14577200A patent/IL145772A0/xx unknown
- 2000-04-05 NZ NZ515026A patent/NZ515026A/en unknown
- 2000-04-05 AU AU41156/00A patent/AU765244B2/en not_active Ceased
- 2000-04-05 TR TR2001/02912T patent/TR200102912T2/xx unknown
- 2000-04-05 BR BR0009674-1A patent/BR0009674A/pt not_active IP Right Cessation
- 2000-04-05 SK SK1422-2001A patent/SK14222001A3/sk not_active Application Discontinuation
- 2000-04-05 PL PL00352824A patent/PL352824A1/xx unknown
- 2000-04-05 HU HU0202401A patent/HUP0202401A3/hu unknown
- 2000-04-05 US US09/958,349 patent/US7144902B1/en not_active Expired - Fee Related
-
2001
- 2001-10-05 BG BG105986A patent/BG105986A/bg unknown
- 2001-10-08 NO NO20014875A patent/NO20014875L/no not_active Application Discontinuation
-
2002
- 2002-10-30 HK HK02107849.6A patent/HK1046289A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
BR0009674A (pt) | 2002-01-15 |
SK14222001A3 (sk) | 2002-07-02 |
TR200102912T2 (tr) | 2002-03-21 |
HUP0202401A2 (en) | 2002-10-28 |
WO2000061609A3 (fr) | 2001-03-15 |
HK1046289A1 (zh) | 2003-01-03 |
EP1165601A2 (fr) | 2002-01-02 |
AU765244B2 (en) | 2003-09-11 |
AU4115600A (en) | 2000-11-14 |
CA2370267A1 (fr) | 2000-10-19 |
PL352824A1 (en) | 2003-09-08 |
JP2002542165A (ja) | 2002-12-10 |
WO2000061609B1 (fr) | 2001-04-26 |
BG105986A (bg) | 2002-06-28 |
WO2000061609A2 (fr) | 2000-10-19 |
HUP0202401A3 (en) | 2003-11-28 |
NZ515026A (en) | 2003-10-31 |
KR20010108481A (ko) | 2001-12-07 |
US7144902B1 (en) | 2006-12-05 |
IL145772A0 (en) | 2002-07-25 |
NO20014875D0 (no) | 2001-10-08 |
CN1355810A (zh) | 2002-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE237329T1 (de) | Metalloprotease inhibitoren | |
DE60017180D1 (de) | Fab i inhibitoren | |
NO20012980L (no) | Proteaseinhibitorer | |
PT1224195E (pt) | C-aril-glicosidos inibidores de tgls2 | |
PT1194404E (pt) | Inibidores de aspartil-protease | |
DK1175400T3 (da) | Renininhibitorer | |
ATE524441T1 (de) | Vla-4-inhibitoren | |
CY2012007I1 (el) | Πεπτιδομιμητικοι αναστολεις πρωτεασης | |
DE60008527D1 (de) | Zellproliferation inhibitoren | |
DE60035039D1 (de) | Renin inhibitoren | |
DK1272488T3 (da) | Tri-aryl-substitueret ethan-PDE4-inhibitorer | |
NO20014243D0 (no) | Dihetero-substituerte metalloprotease inhibitorer | |
NO20014875D0 (no) | Promedikamenter for trombin inhibitorer | |
NO20023013D0 (no) | Substituerte 8-arylkinolinfosfodiesterase-4-inhibitorer | |
NO20003814L (no) | Trombininhibitorer | |
NO20021658L (no) | Asfaltenhemmere | |
ATE252547T1 (de) | Matrixmetalloproteinaseinhibitoren | |
PT1189929E (pt) | Inibidores do factor viia | |
PT1339695E (pt) | Inibidores da farnesiltransferase | |
DE60009260D1 (de) | Thiopyranderivate as mmp-inhibitoren | |
AR028075A1 (es) | Inhibidores de la peptido-desformilasa | |
EP1189618A4 (fr) | Inhibiteurs de la thrombine | |
DOP2001000307A (es) | Inhibidores de thrombin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |